Related references
Note: Only part of the references are listed.Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience
Hossam Abdelaziz et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)
Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients
Montserrat Laguno et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
Nadine Kronfli et al.
CLINICAL INFECTIOUS DISEASES (2021)
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment
Domenico Iossa et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus-coinfected patients treated by all-oral direct-acting antivirals
Pin-Shuo Su et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)
Hepatitis C Virus Uses Host Lipids to Its Own Advantage
Malgorzata Sidorkiewicz
METABOLITES (2021)
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
Martina Spaziante et al.
VIRUSES-BASEL (2021)
Sustained virological response at week 12 after interferon-free therapy as criterion for HCV cure definition: Validation in a real-life cohort of HIV-coinfected patients
Lourdes Dominguez-Dominguez et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2020)
Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents
Silvia Goni Esarte et al.
GASTROENTEROLOGIA Y HEPATOLOGIA (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection
J. J. Malin et al.
HIV MEDICINE (2019)
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients
Patrice Cacoub et al.
AMERICAN HEART JOURNAL (2018)
All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings
Juan Berenguer et al.
HEPATOLOGY (2018)
Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus-coinfected patients treated with direct-acting antivirals
G. Fabbri et al.
HIV MEDICINE (2018)
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis
Salvatore Petta et al.
JOURNAL OF HEPATOLOGY (2018)
Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals
Veronika Pietsch et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment
Stefano Gitto et al.
ANNALS OF HEPATOLOGY (2018)
Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men
Andrew L. Foster et al.
CLINICAL INFECTIOUS DISEASES (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Acute hepatitis C in the HIV-infected homosexual male: A second wave of HIV/HCV coinfection?
Juan A. Pineda et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2015)
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
Salvatore Petta et al.
HEPATOLOGY (2015)
Effect of Sofosbuvir and Ribavirin Treatment on Peripheral and Hepatic Lipid Metabolism in Chronic Hepatitis C Virus, Genotype 1-Infected Patients
Eric G. Meissner et al.
HEPATOLOGY (2015)
Low Risk of Liver Decompensation Among Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients With Mild Fibrosis in the Short Term
Juan Macias et al.
HEPATOLOGY (2015)
Chronic hepatitis C virus infection and lipoprotein metabolism
Yoshio Aizawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
What is chemsex and why does it matter?
Hannah McCall et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
What is chemsex and why does it matter?
Hannah McCall et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
Ludovico Abenavoli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
HIV, Age, and the Severity of Hepatitis C Virus-Related Liver Disease A Cohort Study
Gregory D. Kirk et al.
ANNALS OF INTERNAL MEDICINE (2013)
Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients
Hsin-Ming Wang et al.
LIVER INTERNATIONAL (2013)
Hepatitis C virus hijacks host lipid metabolism
Gulam H. Syed et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients
Pablo Labarga et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection:: Assessment using transient elastometry and the role of HCV genotype
P Barreiro et al.
CLINICAL INFECTIOUS DISEASES (2006)
Hepatitis C virus induced hypobetalipoproteinemia:: a possible mechanism for steatosis in chronic hepatitis C
L Serfaty et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
